The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/Objective-Angiogenesis requires tightly coordinated crosstalk between endothelial cells (ECs) and stromal cells, such as fibroblasts and smooth muscle cells. The specific molecular mechanisms moderating this process are still poorly understood. Methods and Results-Stromal cell-derived factors are essential for EC sprouting and lumen formation. We therefore compared the abilities of 2 primary fibroblast isolates and a primary smooth muscle cell isolate to promote in vitro angiogenesis, and analyzed their secretomes using a combination of nano liquid chromatography-mass spectrometry/ mass spectrometry, quantitative PCR, and ELISA. Each isolate exhibited a different level of angiogenic ability. Using quantitative MS, we then compared the secretomes of a fibroblast isolate exhibiting low angiogenic activity, a fibroblast isolate exhibiting high angiogenic activity, and human umbilical vein ECs. High angiogenic fibroblast supernatants exhibited an overabundance of proteins associated with extracellular matrix constituents compared with low angiogenic fibroblasts or ECs. Finally, small interfering RNA technology and purified protein were used to confirm a role for stromal cell-derived hepatocyte growth factor and fibronectin in inducing EC sprouting.
A ngiogenesis is the growth of new blood vessels from the existing vasculature. Angiogenesis occurs not only during normal processes, such as development of the cardiovascular system and wound healing, but also during pathological events, such as tumor growth, diabetic retinopathy, and cardiovascular disease. 1, 2 Cardiovascular disease is the leading cause of mortality in the Western world with >16 million deaths per year, and much of this is associated with atherosclerosis, 3 which is a major contributor to myocardial infarction. 4 Although there is debate as to whether angiogenesis is harmful or beneficial during atherosclerosis, it is clear that this process occurs during disease progression. 1 Endothelial cell (EC) tube formation requires coordinated crosstalk between EC and other cells present in the stromal compartment, such as fibroblasts and smooth muscle cells (SMC), that support blood vessel growth and maturation. 2, 5 During atherosclerosis, SMCs from the medial layer dedifferentiate and migrate into the intima, where they proliferate and synthesize extracellular matrix (ECM), [6] [7] [8] proteases, and angiogenic growth factors, all of which contribute to angiognenesis. [9] [10] [11] [12] [13] Fibroblasts are the predominant nonmyocyte cell found in the heart and infiltrate to the infarcted area after myocardial infarction, where they proliferate 14 and promote angiogenesis. 15 A number of studies have indicated that fibroblasts, like SMC, promote angiogenesis through the production of ECM, proteases, and growth factors. [16] [17] [18] [19] To date, there is no effective treatment to repair damaged heart tissue after myocardial infarction, and recent research has focused on tissue-engineering approaches that replace damaged heart tissue. [20] [21] [22] One study showed that ECM scaffolds derived from cardiac tissue and injected into the hearts of Harlan Sprague-Dawley rats promoted vessel infiltration. 23 Kreutziger et al 24 found that stromal cells were required to prevascularize tissue grafts, and grafts generated in the presence of high angiogenic (HA) stromal cells improved in vivo vessel formation in the infarct zone. It is therefore important to carefully define, at the molecular level, the contributions of these cells to the angiogenic process so that optimal combinations and concentrations of proteins and cell types can be applied in these therapies.
To accomplish this, attention needs to be paid to the experimental systems used to identify and verify the function of these proteins. Studies from Bissel's group, as well as others, have shown that cellular cocultures in 3-dimensional ECMs can accurately model the morphological changes that occur in vivo. 25, 26 In this study, we make use of an in vitro model of angiogenesis where EC are cocultured with stromal cells, such as fibroblasts or SMC in 3-dimensional fibrin gels, to identify stromal cell-secreted proteins important for angiogenesis. Specifically, we compare secreted proteins from EC, fibroblasts, and SMC. Additionally, we compare the levels of proteins secreted by a fibroblast isolate with HA activity to one that has low angiogenic (LA) activity and find that ECM proteins, including fibronectin, are more abundant in fibroblasts with HA activity. Finally, we confirm a role for hepatocyte growth factor (HGF) and fibronectin as stromal cell-secreted proteins important for vessel sprouting.
Materials and Methods

Cell Isolates and Tissue Culture
Primary human umbilical vein endothelial cells (HUVEC) were isolated from umbilical cords obtained from local hospitals under University of California, Irvine Institutional Review Board approval. HUVEC were routinely cultured in M199 (GIBCO, Life Technologies Inc.) with 10% fetal bovine serum and endothelial growth supplement (BD Biosciences). Primary, normal human lung fibroblasts were purchased from Lonza and routinely cultured in M199 with 10% fetal bovine serum. These cells were originally from the same isolate, but since their original isolation, the individual batches have shown phenotypic drift, such that we now have subisolates that have developed difference in angiogenic capabilities. The fibroblasts are characterized by Lonza as being negative for von Willebrand factor, cytokeratins 18 and 19, and α-smooth muscle actin, indicating that they are not SMC. Normal human bronchial SMC were purchased from Lonza and routinely grown in Dulbecco's modified eagle medium (GIBCO) with 10% fetal bovine serum. The SMC are characterized by Lonza as being negative for von Willebrand Factor and postive for α-smooth muscle actin.
Fibrin Gel Angiogenesis Assay
The 3-dimensional in vitro model of angiogenesis was performed, as described previously. 27 Briefly, p3 HUVEC were cultured on collagen-coated Cytodex microcarrier beads (Sigma-Aldrich Co, St Louis, MO). These beads were then embedded into a fibrin gel with or without stromal cells in 24-well plates. Gels were allowed to clot and 1 mL of endothelial growth medium-2 (Lonza) with stromal cells was added to each well. Medium was changed every other day for the first 6 days. For studies involving protein addition, proteins were mixed at the indicated concentrations in endothelial growth medium-2, which contains vascular endothelial growth factor (VEGF) and other proangiogenic factors, and added to gels every other day until the assay was analyzed. For assays involving fibronectin addition, purified fibronectin (BD Biosciences, Bedford, MA) was added to fibrinogen before clotting at the indicated concentrations.
For quantification of sprouting, only sprouts with lengths greater than or equal to the diameter of the bead were counted and at least 20 beads per condition were counted. Lumen formation was quantified by counting the number of EC sprouts that had formed lumens and are expressed as a percentage (% lumenized).
Preparation of Fibroblast, SMC, and HUVEC Conditioned Medium
Normal human lung fibroblasts, SMC, and HUVEC cultured in M199 containing 10% fetal bovine serum were allowed to grow to 80% confluence. Medium was replaced with endothelial growth medium-2 (Lonza) for 1 day and then replaced with serum-free EBM-2. CM was harvested and filtered through a 0.22-μm filter 2 days later. Two volumes of acetonitrile containing 0.1% trifluoroacetic acid were added to the filtered supernatants, and this solution was vortexed for 2 minutes before centrifuging at 14 000g for 5 minutes.
In-Solution Trypsin Digestion and Dimethyl Labeling
Samples were suspended in 50 mmol/L of triethylammonium bicarbonate (Sigma-Aldrich, St. Louis, MO) and 0.5% sodium deoxycholate, and subsequently treated with 5 mmol/L tris 2-carboxyethyl phosphine (5 mmol/L, Thermo Pierce, Rockford, IL) at room temperature for 20 minutes. Samples were then alkylated with iodoacetamide (10 mmol/L final concentration, Sigma) in the dark at room temperature for 20 minutes. The reduced and alkylated samples were digested at a substrate-to-enzyme ratio of 1:50 (wt/wt) with proteomics-grade trypsin (Sigma) at 37°C overnight. Deoxycholate were removed from the digest via phase transfer surfactant method. 8 Samples were next vacuum-dried then labeled with stable isotope dimethyl labeling. 29 The resultant dimethyl-labeled tryptic peptides were applied to C18-StageTips or fractionated into 5 vials using SCX-StageTips. 30
NanoLC-MS System
Nano liquid chromatography-mass spectrometry/mass spectrometry (nanoLC-MS/MS) analyses were conducted using LTQ linear ion trap (Thermo Fisher Scientific, Rockford, IL) coupled with Waters 600E HPLC pump (Waters, Milford, MA) with 1:1000 split and Famous autosampler (Dionex, Sunnyvale, CA). Halo C18 materials (MaC-MOD, Chadds Ford, PA) were packed into P-2000 (Sutter Instrument, Novato, CA) laser-pulled needle (15 cm×75 μm inside diameter) with nitrogen-pressurized Capillary Column Packing bomb (Western Analytical, Lake Elsinore, CA). Mobile phases consisted of 0.1% formic acid (FA) in water and 0.1% FA in acetonitrile, solvent A and B, respectively, over 220 minutes at a flow rate of 200 nL/min with 2% to 35% gradient. The top 5 precursor ions were selected for MS/MS scans with normalized collision-induced dissociation set to 35.
Database Search and Quantitation
Spectral peak processing used MASCOT Distiller, version 2.3.2.0 (Matrix Science, London, United Kingdom), with LCQ_plus_ zoom.opt parameters and a precursor tolerance of 1.2 Da. Peptide searches were against SwissProt (57.1; human taxonomy) with (fixed mod) cysteine carbamiodomethylation and (variable mods) methionine oxidation, along with heavy, intermediate, and light dimethyl label selected for both N-terminus and lysine. 29 The homology threshold (expected, 0.05) was applied for protein ID. Spectral quantitation was done using MASCOT Distiller with simple ratio selected and elution time shift set to 15 seconds. Protein abundance ratios were weighted by geometric means of values from individual peptides after filtering on the basis of goodness-offit and visual inspection. 31
Transfection of Small Interfering RNAs
Small interfering RNAs designed to HGF were obtained from Ambion, Inc (Austin, TX). Transfection was performed using Lipofectamine (Invitrogen, St. Louis, MO), according to the manufacturer's recommended protocol.
Quantification Real-Time PCR, ELISA, and Western Blots
RNA was isolated from normal human lung fibroblasts and SMC using Trizol (Invitrogen, St. Louis, MO), according to the manufacturer's recommended protocol. Three micrograms of RNA was used for cDNA synthesis using the iScript cDNA Synthesis kit (Bio-Rad, Madison, WI). Primers were synthesized by integrated DNA technologies, and sequences can be found in Table IV in the online-only Data Supplement.
ELISA kits were purchased from R&D Systems (Minneapolis, MN). Monoclonal anticollagen, type I antibody, cat # C2456, was purchased from Sigma-Aldrich Co. Densitometry analysis was done using ImageJ (Adobe Systems Inc, San Jose, CA).
Microscopy/Imaging and Statistical Analysis
Visualization of fibrin gel bead assays was performed using brightfield or fluorescent images collected on an inverted microscope (Olympus IX70) with a SPOT Idea 3.0 megapixel color mosaic camera and SPOT software (SPOT Imaging Solutions, Sterling Heights, MI). Images were processed in ImageJ to adjust contrast and color balance. All images in a given experiment were treated identically.
Analyses of HUVEC sprouting and lumen formation in fibrin gel angiogenesis assays were performed by observers blinded to the experimental conditions at the indicated time points. Data shown are representative of 3 independent experiments, unless otherwise indicated. Error bars represent standard error of the mean. For comparisons involving 3 cell isolates, a 1-way ANOVA was performed to determine if the cell isolates affected the output. For comparisons between 2 isolates in the group of 3, the TukeyHSD probability value was used to assess significance. The differences between experimental groups of equal variance when only 2 groups were being compared were analyzed using Student's t test.
Results
Stromal Cells Vary in Their Ability to Support Angiogenesis In Vitro
To assess the ability of different stromal cell types to support angiogenesis, we compared primary isolates of fibroblasts and SMC in a previously described in vitro angiogenesis assay. 27, 32 In this assay, HUVECs are allowed to adhere to collagen-coated cytodex beads, which are then embedded in a 3-dimensional fibrin matrix. Stromal cells are plated within the gel or on top of the gel. The stromal cells secrete factors that, in combination with the growth factors present in the medium, induce EC sprouting and lumen formation. In the absence of the stromal cells, there is minimal sprouting and no lumen formation.
After 10 days of coculture, with the stromal cells on top of the gel, we analyzed the number of EC sprouts and the percentage of sprouts that had formed lumens ( Figure 1 ). The stromal cells analyzed varied in their ability to support EC sprouting and lumen formation. One fibroblast isolate induced the highest number of EC sprouts ( Figure 1A and 1B) and will be referred to as HA fibroblasts. A second fibroblast isolate induced the lowest level of EC sprouting and supported the lowest percentage of EC lumen formation, and this isolate is denoted LA fibroblasts. SMC supported a level of EC sprouting in between the fibroblast isolates, although a higher percentage of these sprouts formed lumens ( Figure 1C ). The differences were found to be highly statistically significant by ANOVA (P<0.01), confirming that stromal cells vary in their ability to support angiogenesis. We next assessed the level of VEGF secreted by each cell isolate by harvesting cell culture supernatants and performing ELISA. Interestingly, there was only a slightly significant difference in the levels of VEGF produced by the 3 cell isolates ( Figure 1D ; ANOVA, P=0.03), however the amount of VEGF in the medium, which is on the order of ng/mL, is far greater than the amount of VEGF secreted by the stromal cells used in this study and, therefore, the differences in their abilities to support angiogenesis was not a result of differences in VEGF secretion.
During the course of our experiments, we observed that HA fibroblasts invaded the fibrin gels after just 2 days of culture, whereas LA fibroblasts did not exhibit significant gel invasiveness even after 10 days (data not shown). Previous work from our group showed that decreasing the distance between fibroblasts and EC in the fibrin gel angiogenesis assay correlates with increased vessel network formation. 22 We therefore reasoned that the higher angiogenic ability of HA fibroblasts could be a result of the shorter distance between them and the EC, as a result of them migrating into the fibrin gel. We tested this hypothesis by performing the angiogenesis assay A Low Angiogenic Fib. with the fibroblasts embedded in the fibrin gel as opposed to on top, thus immediately placing them in closer proximity to the EC. HUVEC were transduced with retrovirus expressing mCherry to allow for distinction between them and the fibroblasts. Even in this orientation, the LA fibroblasts still failed to induce angiogenesis to the same extent as HA fibroblasts ( Figure 1E-1G ), thus ruling out the possibility that differences in fibroblast induction of angiogenesis were merely the result of increased invasiveness, and thereby closer apposition, of the HA fibroblasts.
Identification of Fibroblast and Smooth Muscle Cell Secreted Proteins
Based on the differences in the abilities of these stromal cells to induce angiogenesis, we decided to use these cells as a tool to identify secreted proteins that could regulate angiogenesis. We reasoned that differences in their ability to induce angiogenesis may have been the result of differences in the respective secretomes of LA fibroblasts, HA fibroblasts, and SMC, that is, their ability to condition the local microenvironment, with either ECM proteins, growth factors, or with both. In support of this hypothesis, we have previously shown that fibroblast-conditioned medium supports EC sprouting and lumen formation in the absence of fibroblasts in our in vitro angiogenesis assay. 19 Therefore, we harvested supernatants from cell cultures grown in monolayer and used nanoLC-MS/MS to identify proteins that were secreted by each cell type. Table 1 lists a subset of proteins that were identified, and the cell type(s) from which they were most prominently secreted. A complete list of the proteins identified can be found in Table I in the online-only Data Supplement. Of note, all cells expressed transforming growth factor β-induced protein ig-h3 (βig-h3), collagen type 1, α-1 (Col1A1), insulin-like growth factor-binding protein 7, procollagen C-endopeptidase enhancer 1 (PCOLCE), and secreted protein acidic and rich in cysteine (SPARC). These proteins have previously been identified by our laboratory as being necessary for EC lumen formation in the fibrin gel angiogenesis assay. 19 The fact that all cell types tested secreted these proteins is in agreement with the ability of each stromal cell type to support EC lumen formation, albeit to greater or lesser degrees.
We designed primers to a subset of these genes and used quantitative real-time PCR (qRT-PCR) to confirm mRNA expression of the proteins previously identified by nano-LC-MS/MS. Figure 2 shows that SPARC, Col1A1, and PCOLCE mRNA was detected in all cell types, validating the results obtained using high-performance liquid chromatography/MS. We also noted that several growth factors, including HGF and stromal cell-derived factor, were only detected in the SMC sample during MS analysis (Table 1) , whereas others, for example, angiopoietin 1, stem cell factor, and VEGF-C, were not detected in any cell type by MS. (Table 1 ). This could be because of the fact that many growth factors have K D values in the low nanomolar range and are therefore present in supernatants at much lower concentrations compared with the other proteins that were detected using high-performance liquid chromatography/MS. For example, the ligand-receptor pairs of stromal cell-derived factor/CXCR4 and stem cell factor/c-Kit have reported K D values of 5 to 10 nmol/L and 2 nmol/L, respectively, [33] [34] [35] and the ligands are consequently secreted at similarly low levels. This observation prompted us to perform qRT-PCR on several of these growth factors, and we found that, in contrast to the MS data, all of the genes tested were expressed at the mRNA level in all stromal cell types ( Figure 2D-2H ). HGF was also confirmed by ELISA to be present in cell culture supernatants of both fibroblast isolates and SMC, but not HUVEC ( Figure 2I ).
Assessment of Protein Levels in LA Fibroblasts, HA Fibroblasts, and HUVEC Secretomes
To gain a more quantitative understanding of protein expression by stromal cells in HA versus LA fibroblasts, we preformed nanoLC MS/MS on conditioned media from the isolates. Here, size-fractionated protein extracts of conditioned media from the 3 cell types were first digested with trypsin and the resulting peptides were then individually isotope labeled. The labeled samples were combined, and peptide fractionation was followed by nanoLC-MS/MS. Peptides were identified from fragmentation spectra, and their relative abundances in the 3 samples were quantitated from areas under the corresponding precursor level MS isotopologues. HUVEC served as a negative control as EC do not undergo angiogenic sprouting and lumen formation, when cultured in the absence of stromal cells. Table 2 lists proteins identified that scored above the Mascot homology/identity threshold along with their corresponding abundance ratios in the 3 cell types analyzed (a more comprehensive list can be found in Table II in the online-only Data Supplement). Peptides from 687 unique accessions that passed quantitation quality-filtering were identified in the 3 cell types tested. Of note, several proteins whose abundance ratios were skewed in favor of the angiogenic isolate have previously been shown to be proangiogenic, including matrix metalloproteinase 2, 4,36 fibronectin, 37 and clusterin. 38 These were found to be present at substantially higher levels in the HA fibroblast supernatants than in either the LA fibroblast or HUVEC supernatants ( Table 2) .
We addressed differentially abundant proteins at the mRNA level using qRT-PCR, as well as Western blot analysis. Figure 3 shows that matrix metalloproteinase 2, βig-h3 and fibronectin were all expressed at higher levels in HA fibroblasts than in LA fibroblasts. Interestingly, Col1A1 and PCOLCE had similar levels of mRNA in HA fibroblasts and LA fibroblasts ( Figure 2B and 2C) , which is in agreement with data obtained via quantitative MS/high-performance liquid chromatography. Online-only Data Supplemental Figure I in the online-only Data Supplement shows the level of various collagen 1 isoforms in LA and HA fibroblasts as well as SMC supernatants detected by Western blotting. Here, the high molecular weight band corresponds to dimeric and trimeric collagen 1 and the low molecular weight band corresponds to monomeric collagen 1. These cells secreted similar levels of collagen 1, which is in agreement with data obtained via quantitative MS. 
Numerous Extracellular Matrix Proteins Are Overabundantly Expressed in HA Fibroblast Supernatants
To ascertain whether specific functional classes of proteins were overabundant in HA fibroblast secretomes versus those from LA fibroblasts or HUVEC, all nodes of the entire ≈33 000 node gene ontology (GO) tree to which >9 of our 687 accession could be assigned were screened for a skew in the distribution of all of the relative quant ratios (HA fibroblasts/ LA fibroblasts, LA fibroblasts/HUVEC, or HA fibroblasts/ HUVEC). The criterion set for a skew was that the number of individual quant ratios lying on one side of the global median for all 687 unique accessions was at least 2.5× the number lying on the other side. Such a skew was taken to indicate that proteins of a particular functional class were substantially overabundant or underabundant with respect to the 687-member secretome as a whole. Based on these criteria, 2292 of the ≈33 000 GO terms were assignable to accessions in our set and, of these, 28 exhibited the aforementioned skew. These are displayed in Figure 4A , with gray boxes representing terms that were underabundant for the indicated ratio and black boxes representing terms that were overabundant for the given ratio.
Of the 28 GO terms exhibiting skew, 3 were found to be overabundant in the HA fibroblasts compared with the LA fibroblasts ( Figure 4A ). Interestingly, all 3-ECM structural constituent, extracellular space, and proteinaceous ECMrelate to proteins associated with ECM deposition and assembly. Figure 4B shows histogram representations of proteins mapping to the extracellular space term that were overabundant in HA fibroblast compared with LA fibroblasts and HUVEC. Because all 3 GO terms that exhibited skew between HA fibroblasts and LA fibroblasts were ECM terms and some accessions appeared in more than 1 GO term, we wanted to determine whether this was a result of the same accessions appearing in multiple GO terms. Therefore, we made a visual representation of the numbers of proteins that were identified in multiple ECM GO terms ( Figure 4C ). As is evidenced by the Venn diagram, there is little overlap between the proteins identified as ECM structural constituent, exctracellular space, and proteinaceous ECM. Table III in the online-only Data Supplement lists the specific proteins that were identified in each ECM GO term.
HGF and Fibronectin Induce EC Sprouting
We have previously identified a combination of proteins, of which HGF is a component, that induces EC sprouting in the absence of fibroblasts. 24 In addition, we have shown here that fibroblasts and SMC make substantial amounts of HGF, whereas EC do not ( Figure 2I ). To determine whether stromal cell-derived HGF was required for EC sprouting, we obtained 2 small interfering RNAs targeted to different regions of the HGF gene and transfected HA fibroblasts to knock down HGF *Indicates proteins that were found in the upper 10th percentile of the corresponding ratio.
†Indicates proteins that were found in the lower 10th percentile of the corresponding ratio. gene expression. These fibroblasts were then used in the fibrin gel angiogenesis assay. HGF knockdown was confirmed by qRT-PCR ( Figure 5F ), and to ensure that HGF levels had not returned to basal levels, the fibrin gel angiogenesis assay was analyzed on Day 5. When fibroblasts were treated with either of the small interfering RNAs designed to HGF, EC sprouting was significantly decreased ( Figure 5A and 5B), whereas lumen formation was unaffected ( Figure 5C ). Similarly, knockdown of HGF in SMC also led to a decrease in EC sprouting and no change in EC lumen formation ( Figure IIA and IIB in the online-only Data Supplement). Thus, the ability of multiple stromal cell types to promote EC sprouting is critically dependent on secreted HGF.
Additionally, we examined the effect of HGF addition in the fibrin gel angiogenesis assay in the presence of LA fibroblasts, in an attempt to increase EC sprouting. Indeed, addition of HGF increased EC sprouting, and this increase was dependent on HGF concentration ( Figure IIC and IID in the online-only Data Supplement). As the angiogenic response of LA fibroblasts is weaker and slower than the HA fibroblasts, these cultures were analyzed at Day 14.
We also attempted to increase EC sprouting in the presence of the LA fibroblasts by spiking ECM proteins into the fibrin gels. Fibronectin was chosen because of the fact that it was overabundantly expressed by the HA fibroblasts compared with LA fibroblasts ( Table 2 ). Addition of fibronectin induced a singnificant, dose-dependent increase in EC sprouting ( Figure 5D and 5E). These results demonstrate that fibroblasts and SMC contribute to angiogenic sprouting in multiple ways; by secreting HGF, which induces sprouting and also by secretion of a complex ECM, which contributes not only to sprouting, but also to lumen formation.
Discussion
In this study, we demonstrate that different stromal cell populations vary in their ability to support in vitro vessel formation and that these differences can, at least in part, be attributed to differences in their secretomes. We took advantage of the differences in angiogenic activity in these stromal cell isolates to identify specific proteins that regulate this process. Interestingly, fibroblasts that exhibited HA activity expressed higher levels of proteins associated with the ECM compared with fibroblasts with LA activity. Importantly, addition of the ECM protein fibronectin was shown to robustly restore angiogenic activity to the LA fibroblasts. The fact that HA fibroblasts overabundantly expressed ECM proteins is consistent with previous studies demonstrating a positive role for ECM proteins in regulating angiogenesis. 18, 19, 39 Fibronectin can bind other proteins present in the ECM, such as heparin, collagen, and fibrin; all of which are present in the fibrin gel angiogenesis assay. [40] [41] [42] With this in mind, it is plausible that ECM-fibronectin interactions could alter EC response to these matrices. Indeed, one study has shown that fibronectin regulates fibroblast migration into fibrin clots, suggesting a pivotal role for fibronectin-fibrin interactions in regulating cell migration. 43 ECs bind to ECM and respond to changes in ECM composition through integrins. A number of integrins have been shown to be important for EC migration, including α 1 β 1 , α 1 β 2 , and α v β 3 . 44, 45 The fibronectin-binding integrin, α 5 β 1 , has been shown to regulate angiogenesis in vivo. 46 Also of interest to this study, Mitra et al 47 showed that blocking the α 5 β 1 integrin with a functionblocking antibody decreased phosphorylation of the HGF receptor, mesenchymal epithelial transition factor (cMET), in HUVEC plated on fibronectin, and we show here a critical role for stromal cell-derived HGF in EC sprouting. Kreutziger et al 24 found that increased angiogenesis correlated with increased expression of the ECM component versican in cocultures of EC and different mesenchymal stem cell lines.
Interestingly, we only detected versican expression in SMC in our MS analysis. As no studies of versican knock down or inhibition were reported in the aforementioned study, it is difficult to determine whether versican indeed stimulates angiogenesis. Alternatively, different stromal cells may induce angiogenesis via different pathways.
HGF has previously been shown to regulate angiogenesis both in vivo and in vitro. [48] [49] [50] [51] Our results further these findings by demonstrating that stromal cells, fibroblasts, and SMCs, in particular, are important sources of HGF during angiogenesis. Evidence for this is provided by ELISA data showing that LA fibroblasts, HA fibroblasts, and SMCs secrete HGF ( Figure 2I) , and that knocking down HGF expression in HA fibroblasts and SMC leads to decreased EC sprouting ( Figure 5A and 5B ). It should be noted that HGF was not detected via MS analysis of HA or LA supernatents, but was detected via qPCR and ELISA. This is likely because of the fact that growth factors such as VEGF and HGF are secreted at much lower levels in comparison with ECM proteins, such as those identified via MS. It would be interesting to identify the signaling proteins downstream of HGF-cMET signaling in EC that are responsible for mediating this increase in EC migration, and to determine to what extent crosstalk between HGF and fibronectin signaling through cMET is required.
The role that angiogenesis plays in cardiovascular disease remains controversial, 1 but it is clear that fibroblasts and SMC contribute to the process, 15 although the molecular mechanisms that regulate these activities remain poorly defined. The results presented here begin to unravel these molecular mechanisms, and have implications for the treatment of cardiovascular disease by demonstrating that ECM proteins as well as HGF are important contributors to angiogenesis, and that alteration in the levels of these proteins can either promote or inhibit blood vessel growth. This study also identifies a number of proteins that could be potentially useful in tissue-engineering approaches to repair damaged heart tissue after myocardial infarction.
Tissue-replacement strategies to repair damaged heart tissue are dependent on the ability of the grafted tissue to survive in the hostile ischemic microenvironment. One attractive strategy for improving graft tissue survival is to create prevascularized tissue constructs in the hopes that host vessels will rapidly anastomose with graft vessels. Indeed, prevascularized tissue constructs have been shown to improve tissue viability on in vivo transplantation, with several studies showing that increased vascularization led to increased tissue survival. 24, [52] [53] [54] Knowledge of the cell types and signaling proteins that regulate and promote angiogenesis will help guide research into optimization of tissue constructs or injectable ECM gels. Our data indicate that tissue constructs containing stromal cells high in ECM protein production will improve graft viability by increasing angiogenesis.
Angiogenesis requires crosstalk between EC and other cells of the stromal compartment and a clear understanding of the molecules regulating this process will be critical for any strategies involving manipulation of angiogenesis. 
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